Q1 2019 Atara Biotherapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Atara Biotherapeutics First Quarter 2019 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this conference call will be recorded.
I will now turn the call over to Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics. Please go ahead, sir.
Thank you, operator. Good morning, everyone, and welcome to the Atara First Quarter 2019 Financial Results and Corporate Update Conference Call. Earlier this morning, we issued a press release providing an overview of the company's first quarter 2019 financial results and recent operational progress. Please note that this press release is available in the Investors & Media section at atarabio.com.
I'm joined on the call today by Dr. Isaac Ciechanover, President and Chief Executive Officer; Dr. Dietmar Berger, Global Head of R&D; and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |